MNPR peer analysis

Monopar Therapeutics (MNPR) against its competitors: price, today's move, 1-year return and market value side by side.

MNPR and its peers

CompanyPriceToday1-year returnMarket cap
ADCT ADC Therapeutics$1.28-1.54%-68.16%$180.05M
ALXO ALX Oncology$1.063.92%-27.89%$137.03M
ATNM Actinium Pharmaceuticals$1.07-0.93%-21.32%$33.64M
BCYC Bicycle Therapeutics$2.90-4.92%-53.60%$202.98M
CMPX Compass Therapeutics$0.67-0.87%-86.27%$121.13M
IMNM Immunome$15.69-5.54%-11.31%$1.85B
IPHA Innate Pharma$0.94-8.75%-47.78%$104.99M
MGNX MacroGenics$1.98-0.01%39.43%$126.53M
XNCR Xencor$33.24-2.26%110.78%$2.49B
ZYME Zymeworks$26.14-2.68%15.66%$1.81B
MNPR Monopar Therapeutics$67.35-4.19%-18.86%$456.39M